Brief: Annovis Bio Announces Closing Of $21 Million Public Offering
04/02/2025 22:49
Feb 4 (Reuters) - Annovis Bio Inc ANVS.N :
* ANNOVIS BIO, INC. ANNOUNCES CLOSING OF $21 MILLION PUBLIC
OFFERING
* ANNOVIS BIO INC - PROCEEDS TO FUND PHASE 3 STUDY OF
BUNTANETAP
FOR ALZHEIMER'S
Source text: ID:nGNX7SNjsY
Further company coverage: ANVS.N
((reuters.briefs@thomsonreuters.com;))
Recent news on Annovis Bio
See all newsAnnovis Bio Inc reports results for the quarter ended June 30 - Earnings Summary
Annovis Bio Q2 loss widens as R&D costs rise
Annovis Bio Inc expected to post a loss of 45 cents a share - Earnings Preview
Brief: Annovis Announces Pricing Of $15.0 Million Public Offering Of Common Stock And Accompanying Warrants
U.S. STOCKS ON THE MOVE-Amazon, Northrop Grumman, Brown-Forman